Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The non-canonical NF-kappa B pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro

Full text
Author(s):
Meyerovich, Kira [1] ; Fukaya, Makiko [1] ; Terra, Leticia F. [2] ; Ortis, Fernanda [3] ; Eizirik, Decio L. [1] ; Cardozo, Alessandra K. [1]
Total Authors: 6
Affiliation:
[1] Univ Libre Bruxelles, ULB Ctr Diabet Res, Route Lennik 808, CP 618, B-1070 Brussels - Belgium
[2] Univ Sao Paulo, Inst Chem, Sao Paulo - Brazil
[3] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Diabetologia; v. 59, n. 3, p. 512-521, MAR 2016.
Web of Science Citations: 9
Abstract

Aims/hypothesis Activation of the transcription factor nuclear factor (NF)-kappa B by proinflammatory cytokines plays an important role in beta cell demise in type 1 diabetes. Two main signalling pathways are known to activate NF-kappa B, namely the canonical and the non-canonical pathways. Up to now, studies on the role of NF-kappa B activation in beta cells have focused on the canonical pathway. The aim of this study was to investigate whether cytokines activate the non-canonical pathway in beta cells, how this pathway is regulated and the consequences of its activation on beta cell fate. Methods NF-kappa B signalling was analysed by immunoblotting, promoter reporter assays and real-time RT-PCR, after knockdown or overexpression of key genes/proteins. INS-1E cells, FACS-purified rat beta cells and the human beta cell line EndoC-beta H1 exposed to cytokines were used as models. Results IL-1 beta plus IFN-kappa induced stabilisation of NF-kappa Binducing kinase and increased the expression and cleavage of p100 protein, culminating in the nuclear translocation of p52, the hallmark of the non-canonical signalling. This activation relied on different crosstalks between the canonical and non-canonical pathways, some of which were beta cell specific. Importantly, cytokine-mediated activation of the non-canonical pathway controlled the expression of `late' NF-beta B-dependent genes, regulating both pro-apoptotic and inflammatory responses, which are implicated in beta cell loss in early type 1 diabetes. Conclusions/interpretation The atypical activation of the non-canonical NF-kappa B pathway by proinflammatory cytokines constitutes a novel `feed-forward' mechanism that contributes to the particularly pro-apoptotic effect of NF-kappa B in beta cells. (AU)

FAPESP's process: 10/05587-1 - Study of the differential NF-kB activation in beta cells and the mechanisms that can be modulated for the prevention of its pro-apoptotic effect
Grantee:Fernanda Ortis
Support Opportunities: Research Grants - Young Investigators Grants